documents: FDA-2022-D-1261-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-D-1261-0001 FDA FDA-2022-D-1261 Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention; Draft Guidance for Industry; Availability Notice Notice of Availability 2022-10-28T04:00:00Z 2022 10 2022-10-28T04:00:00Z   2022-10-28T19:26:54Z 2022-23457 0 0 090000648546a16a

Links from other tables